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ABSTRACT Legionella pneumophila governs its interactions with host cells by se-
creting 300 different “effector” proteins. Some of these effectors contain eukaryotic
domains such as the RCC1 (regulator of chromosome condensation 1) repeats pro-
moting the activation of the small GTPase Ran. In this report, we reveal a conserved
pattern of L. pneumophila RCC1 repeat genes, which are distributed in two main
clusters of strains. Accordingly, strain Philadelphia-1 contains two RCC1 genes impli-
cated in bacterial virulence, legG1 (Legionella eukaryotic gene 1), and ppgA, while
strain Paris contains only one, pieG. The RCC1 repeat effectors localize to different
cellular compartments and bind distinct components of the Ran GTPase cycle, in-
cluding Ran modulators and the small GTPase itself, and yet they all promote the
activation of Ran. The pieG gene spans the corresponding open reading frames of
legG1 and a separate adjacent upstream gene, lpg1975. legG1 and lpg1975 are fused
upon addition of a single nucleotide to encode a protein that adopts the binding
specificity of PieG. Thus, a point mutation in pieG splits the gene, altering the effec-
tor target. These results indicate that divergent evolution of RCC1 repeat effectors
defines the Ran GTPase cycle targets and that modulation of different components
of the cycle might fine-tune Ran activation during Legionella infection.
IMPORTANCE Legionella pneumophila is a ubiquitous environmental bacterium
which, upon inhalation, causes a life-threatening pneumonia termed Legionnaires’
disease. The opportunistic pathogen grows in amoebae and macrophages by em-
ploying a “type IV” secretion system, which secretes more than 300 different “effec-
tor” proteins into the host cell, where they subvert pivotal processes. The function
of many of these effector proteins is unknown, and their evolution has not been
studied. L. pneumophila RCC1 repeat effectors target the small GTPase Ran, a molec-
ular switch implicated in different cellular processes such as nucleocytoplasmic
transport and microtubule cytoskeleton dynamics. We provide evidence that one or
more RCC1 repeat genes are distributed in two main clusters of L. pneumophila
strains and have divergently evolved to target different components of the Ran
GTPase activation cycle at different subcellular sites. Thus, L. pneumophila employs a
sophisticated strategy to subvert host cell Ran GTPase during infection.
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During coevolution with eukaryotic host cells, intracellular bacterial pathogensdeveloped large repertoires of translocated “effector” proteins, which modulate
host organelles and processes in sophisticated manners (1, 2). Legionella pneumophila
is an amoeba-resistant environmental bacterium that upon inhalation causes a pneu-
monia called Legionnaires’ disease (3, 4). The opportunistic pathogen injects more than
300 different putative effector proteins through the Icm/Dot (intracellular multiplica-
tion/defective organelle trafficking) type IV secretion system (T4SS) into host cells (1,
5–7). The Icm/Dot-translocated proteins determine the infection process by subverting
signal transduction, cytoskeleton dynamics, and membrane trafficking. Specifically, the
effector proteins govern the formation of the pathogen’s intracellular replication
niche, termed the Legionella-containing vacuole (LCV) (8–10). A crucial feature of
LCVs is the phosphoinositide (PI) lipid conversion from phosphatidylinositol
3-phosphate (PtdIns(3)P) to PtdIns(4)P (11–14). Among the plethora of effectors, only a
few have been functionally characterized, and these target PI lipids (12, 15–19),
sphingolipid metabolism (20), small GTPases (5, 21–25), the ubiquitination machin-
ery (7), trafficking complexes (26–30), protein translation (31–33), or gene transcrip-
tion (34, 35).
Proteomics analyses of intact LCVs purified from either Dictyostelium discoideum
amoebae or macrophages indicated that Ran, Ran binding protein 1 (RanBP1), RanBP2,
RanGAP1 (Ran GTPase-activating protein 1), RCC1 (regulator of chromosome conden-
sation 1), and RCC2 might be host components implicated in pathogen vacuole
formation (36–38). The small GTPase Ran has pleiotropic functions in different com-
partments of eukaryotic cells (39, 40). These include nucleocytoplasmic transport (41),
mitotic spindle assembly and postmitotic nuclear envelope formation (42, 43), as well
as endocytic receptor trafficking (44) and the modulation of cytoplasmic (noncentro-
somal) microtubule dynamics (45). Ran is activated by the guanine nucleotide exchange
factor (GEF) RCC1 (regulator of chromosome condensation 1), which facilitates the
exchange of GDP with GTP (46). In turn, Ran(GTP) is inactivated by cytoplasmic
RanGAP1 in concert with RanBP1, which specifically binds to activated Ran (39, 40). The
presence of Ran and RanBP1 on LCVs during infection was validated by fluorescence
microscopy, and both components of the Ran GTPase cycle were found to be impli-
cated in intracellular replication of L. pneumophila by RNA interference (47).
The genome of L. pneumophila harbors a number of genes encoding proteins whose
closest homologs are eukaryotic counterparts (48–50). Among these, legG1 (lpg1976)
(49), ppgA (lpg2224) (51), and pieG (lpp1959) (51, 52) encode effectors that contain RCC1
repeats predicted with high confidence on the basis of the amino acid sequences.
LegG1 promotes Ran activation, microtubule stabilization, and LCV motility (47). More-
over, LegG1 stimulates the chemotactic migration of D. discoideum, macrophages and
neutrophils, the motility of which is hyperinhibited by an L. pneumophila mutant strain
lacking legG1 (53). LegG1 (alias MitF) is also required for mitochondrion fission and
concomitant inhibition of mitochondrial respiration during L. pneumophila infection
(54). LegG1 and PieG contain a C-terminal CAAX motif, which is prenylated by the host
prenylation machinery, thus facilitating membrane localization of the effector protein
(52).
In this study, we employed bioinformatics and molecular analysis to assess the
evolution and functions of L. pneumophila RCC1 repeat effectors. We show that RCC1
repeat effectors contribute to pathogen-host interactions and promote Ran activation
as well as LCV and host cell motility by targeting different Ran GTPase cycle compo-
nents. Accordingly, divergent evolution of RCC1 effectors defines the range of Ran
GTPase cycle targets and might fine-tune the activation of the GTPase in a spatiotem-
poral manner during infection.
RESULTS
Distribution and structural comparison of L. pneumophila RCC1 repeat effec-
tors. A bioinformatics analysis of Legionella genomes revealed that RCC1 repeat genes
are present in many Legionella species (24 of 58 analyzed) and are conserved in all 59
Swart et al. ®













































L. pneumophila strains examined in this study (Fig. 1). While some of the L. pneumophila
strains contain only one RCC1 repeat effector gene (e.g., strains Lens and Paris:
pieG/lpp1959), others contain two single genes (e.g., strains Philadelphia-1 and C7O:
legG1/lpg1976 and ppgA/lpg2224) or, additionally, a duplicated ppgA gene. Indeed, the
RCC1 repeat genes in L. pneumophila were found to be distributed in two main clusters,
namely, the “Lens-Paris” cluster and the “Philadelphia-C7O” cluster, respectively. Most
of the strains in the Lens-Paris cluster harbor only the pieG gene, the exceptions being
a subcluster of seven strains containing pieG and two or three ppgA genes. The strains
in the Philadelphia-C7O cluster are more closely related to each other and contain a
split pieG gene (yielding lpg1975 and legG1; see below) as well as one ppgA gene. As an
exception, strain E6N harbors single, intact pieG and ppgA genes.
The phylogenetic trees indicate that the RCC1 repeat genes have mostly followed
the evolution of the strain (see Fig. S1 in the supplemental material). Strains E6N and
NCTC11286 are exceptions, as they do not localize with the same strains in the
phylogenetic trees of the strains and lpp1959 genes (Fig. S1A). This suggests that
horizontal gene transfer took place and explains why strain E6N groups with the strains
where lpp1959 is usually split. If present in two or more copies, lpg2224 genes from the
FIG 1 Distribution of L. pneumophila RCC1 repeat genes. The phylogenetic tree of 59 L. pneumophila strains was inferred using the fast core
genome multialigner Parsnp (https://github.com/marbl/parsnp). Circles at nodes represent bootstrap support, and the size of each circle is
proportional to the corresponding bootstrap value. The scale bar represents the estimated number of substitutions per site. For each strain, the
presence or absence of the RCC1 repeat effector genes lpp1959 (pieG) and lpg2224 (ppgA) was assessed by OrthoMCL (https://orthomcl.org), and
all of the strains were found to be distributed in two main clusters. In strain C4S, a split fragment of gene lpp1959 is a pseudogene. Strain
NCTC11404 does not harbor an lpg2224 gene (verified by blast search), and one of three lpg2224 copies in strain D-7630 is a pseudogene.
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same strain do not group together (Fig. S1B). This finding suggests that one or several
duplication events originated in a common ancestor, followed by posterior sequence
divergence (and perhaps functional diversification) among the different duplications
and posterior emergence of new strains from the common ancestor. Taken together,
the data show that RCC1 repeat genes are conserved in L. pneumophila and occur with
a distinct pattern comprising two different strain clusters.
The RCC1 repeat genes of L. pneumophila strain Philadelphia-1 and Paris contain 2
to 3 RCC1 repeats and encode the effectors PpgA (66 kDa) and LegG1/Lpg1976
(31 kDa), or PieG (53 kDa), respectively (Fig. S2). Previously, the acronyms “LegG1” and
“PieG” were used synonymously (51). However, given the distinct features of the
proteins (see below), here we use LegG1 and PieG exclusively for the orthologs of
strains Philadelphia-1 and Paris, respectively. The positions of the predicted RCC1
repeats in the L. pneumophila effectors vary, but the level of homology with the RCC1
repeat of the human Ran GEF RCC1 is very high, and the homologous region includes
the conserved GQLGLGE/D motif but lacks amino acids essential for GEF activity
(Fig. S2). Moreover, structural predictions indicate that the L. pneumophila RCC1 repeat
effectors adopt -propeller structures like human RCC1 (55).
Role of L. pneumophila RCC1 repeat effectors in pathogen-host interactions. To
analyze the function of L. pneumophila RCC1 repeat effectors, strains lacking ppgA
(LS03, ΔppgA), legG1 (ΔlegG1), ppgA and legG1 (LS01, ΔppgA-ΔlegG1), or pieG (LS08,
ΔpieG) were constructed by deleting the genes from the chromosome by double
homologous recombination (see Table S1A in the supplemental material). L. pneumo-
phila ΔppgA, ΔlegG1, ΔppgA-ΔlegG1 (strain Philadelphia-1), and ΔpieG (strain Paris) grew
at the same rate as the parental strains in broth (Fig. S3A and B). Moreover, the
overproduction of PieG (Paris) in strain Philadelphia-1 or of PpgA (Philadelphia-1) in
strain Paris did not impair growth in broth (Fig. S3C and D).
The ΔppgA, ΔlegG1, and ΔppgA-ΔlegG1 mutant strains were slightly but significantly
impaired for intracellular replication in murine RAW 264.7 macrophages (Fig. 2A), but
not in Acanthamoeba castellanii (Fig. S3E). Upon infection of D. discoideum, the ΔppgA-
ΔlegG1mutant strain was killed more efficiently at 24 h (Fig. S3F) but was impaired only
for intracellular replication in a “single-round infection” assay (Fig. 2B). The ΔpieG
mutant strain was slightly but significantly impaired for growth also in a multiple-round
infection assay over several days (Fig. 2C). Upon coinfection of the ΔppgA, ΔlegG1,
ΔppgA-ΔlegG1, or ΔpieG mutant strains with the parental strain at a 1:1 ratio in A.
castellanii, the mutant strains were efficiently outcompeted by wild-type (WT) bacteria
and eradicated within 6 to 9 days (Fig. S3G). Hence, PpgA—alone or in combination
with LegG1—and PieG were essential for competition against wild-type L. pneumophila
upon coinfection of amoebae.
L. pneumophila strains lacking lpg1975 (LS06, Δlpg1975) or ppgA, legG1 and lpg1975
(LS05, ΔΔΔ) were also outcompeted by wild-type bacteria in the amoeba competition
assay (Fig. S3G), but strain Δlpg1975 was not impaired for intracellular replication in
RAW 264.7 macrophages or A. castellanii (Fig. S3H). The competition phenotype of
strain Δlpg1975 was not simply due to the absence of the downstream legG1/lpg1976
gene, since in the mutant strain LegG1 was still produced, as established by mass
spectrometry (Table S2A). Finally, lpg1975 was not required for the Icm/Dot-dependent
translocation of LegG1 or PpgA into host cells (Fig. S3I) and is not an Icm/Dot substrate
itself (51). In summary, the L. pneumophila RCC1 repeat effector PpgA (in particular,
together with LegG1) and PieG contribute to pathogen-host cell interactions.
RCC1 repeat effectors promote LCV motility and cell migration. LegG1 has been
implicated in microtubule stability and LCV motility as well as in host cell motility (47,
53). To assess whether the L. pneumophila RCC1 repeat effector PpgA also affects
pathogen vacuole motility, we infected D. discoideum producing the endoplasmic
reticulum (ER)/LCV marker calnexin-GFP (calnexin-green fluorescent protein) (12) with
red fluorescent L. pneumophila wild-type, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 or with the
complemented strains and analyzed pathogen vacuole dynamics by live-cell fluores-
Swart et al. ®













































cence microscopy (Fig. S4A). Compared to D. discoideum infected for 1 to 2 h with
wild-type L. pneumophila, LCV motility was significantly reduced by 50% in amoebae
infected with the ΔppgA mutant strain (or, as a control, the ΔlegG1 strain) (Fig. 2D). The
LCV motility phenotype was complemented by providing the corresponding ppgA or
FIG 2 L. pneumophila RCC1 repeat effectors and their role in pathogen-host interactions. (A) Murine RAW 264.7macrophages were infected (multiplicity of infection
[MOI] 0.1) with L. pneumophila strain JR32, ΔicmT, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1, the cells were lysed, and intracellular replication at 37°C was assessed by CFU
counting. (B) D. discoideumwas infected (MOI 10) with L. pneumophila strain JR32, ΔicmT, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 producing GFP (pNT28), and intracellular
replication at 25°C was assessed by GFP fluorescence increase. Data show means and standard deviations of results from triplicates (one-way analysis of variance
[ANOVA]; ***, P 0.001). RFU, relative fluorescence units. (C) D. discoideum was infected (MOI 0.1) with wild-type L. pneumophila strain Paris or with the ΔdotA or
ΔpieG mutant strain, and intracellular replication at 25°C was assessed by CFU counting in lysates of infected cells (3 independent experiments; two-way ANOVA;
*, P 0.1; **, P 0.01; ***, P 0.001). (D and E) Real-time fluorescence microscopy of LCV motility in D. discoideum producing calnexin-GFP (pCaln-GFP) infected
(MOI 5, 1 to 2 h) with L. pneumophila JR32, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 producing DsRed alone (pCR077) or together with M45-LegG1 (pER005) or M45-PpgA
(pLS008) (D), or with the Paris wild-type strain or the ΔpieG mutant strain producing DsRed alone (pCR077) or together with M45-PieG (pLS033), M45-LegG1
(pER005), or M45-PpgA (pLS008) (E). LCV motility was recorded for 180 s with images taken every 10 s and quantified using ImageJ/Fiji software with the manual
tracking plugin (n 50/strain; 3 independent experiments; one-way ANOVA; **, P 0.01; ***, P 0.001; compared to the wild-type {D} or ΔpieG {E} strain). (F) D.
discoideum producing GFP (pDM317) was infected (MOI 5, 1 h) with L. pneumophila JR32, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 producing DsRed alone (pCR077) or
together with M45-LegG1 (pER005) or M45-PpgA (pLS008) and was seeded in a culture inset 2-well dish (Ibidi) for 2 h. After removal of the inset, cell migration
was analyzed by confocal microscopy at 0 and 3 h. Bars, 200 m. (G) Cell migration was quantified using ImageJ/Fiji software. The cell density ratio represents the
average fluorescent signal intensity in the 500 m gap divided by the average fluorescent signal intensity in 250m on each side of the gap center (3 independent
experiments; two-way ANOVA; **, P 0.01; ***, P 0.001; all groups compared to wild-type strain at 3 h [t3]). (H) D. discoideum producing GFP-PpgA (pLS078),
GFP-LegG1 (pER017), or GFP-LegG1ΔCAAX (pER016) was infected (MOI 5, 1 h) with L. pneumophila JR32 or ΔicmT producing DsRed (pSW001), and localization of RCC1
repeat effectors was analyzed by confocal microscopy. Bars, 1m.
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legG1 gene on a plasmid under the control of the Ptac promoter. Interestingly, the
phenotype of the ΔppgA strain was reversed by plasmid-borne legG1, while the
phenotype of the ΔlegG1 strain was not reversed by ppgA. This finding suggests that
while both RCC1 repeat effectors promote pathogen vacuole motility, their functions
are not interchangeable. Similarly, upon infection of calnexin-GFP-producing D. discoi-
deum with L. pneumophila strain Paris or the ΔpieG mutant, LCV motility was reduced
by approximately 25% (Fig. 2E). The LCV motility phenotype was reversed by plasmid-
encoded PieG or LegG1, but not by PpgA. Taken together, the L. pneumophila RCC1
repeat effectors PpgA, PieG and LegG1 promote LCV motility, and the functions of PieG
and LegG1, at least regarding LCV motility, seem to be more closely related to one
another than to PpgA.
To determine whether PpgA controls cell motility, we performed “gap closure”
assays, where cell migration occurs to repopulate an area depleted of cells. To this end,
D. discoideum producing GFP was infected with red fluorescent L. pneumophila strain
JR32, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 or with the complemented strains. The infected
amoebae were seeded in a culture inset 2-well dish, and after removal of the inset, cell
migration was analyzed by confocal microscopy at 0 and 3 h (Fig. 2F). D. discoideum
infected with the ΔicmT mutant as well as uninfected amoebae spread efficiently and
increased the cell density in the insertion area by 70% to 90% in the course of the
experiment (Fig. 2G). In contrast, D. discoideum infected with L. pneumophila strain JR32,
ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1 barely migrated, corresponding to an increase of cell
density in the insertion area of merely 25% to 35% at 3 h after the start of the assay.
Upon expression of plasmid-borne legG1 or ppgA, the inhibition of cell migration was
reduced, in agreement with the notion that overproduction of the RCC1 repeat
effectors has a positive effect on cell migration. Accordingly, the infection of amoebae
with the ΔppgA-ΔlegG1 mutant led to a slight (statistically not significant) “hyperinhi-
bition” of cell migration compared to the infection with parental strain JR32. In
summary, these results indicate that the RCC1 repeat effectors PpgA and LegG1 (53)
promote LCV dynamics and cell motility. The effects observed for the ΔppgA and
ΔlegG1 mutant strains seem similar, but interestingly, in some cases they appear
additive.
PpgA is dispensable for Ran activation on LCVs and localizes to the plasma
membrane. To test whether RCC1 repeat effectors play a role for early steps of
pathogen vacuole formation, D. discoideum amoebae producing the PtdIns(4)P probe
P4CSidC-GFP or calnexin-GFP were infected with red fluorescent L. pneumophila strain
JR32, ΔicmT, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1, and GFP-positive LCVs were quantified
by imaging flow cytometry (IFC) (Fig. S4B). The IFC colocalization scores were identical
for the parental and the RCC1 repeat effector mutant strains, indicating that PpgA and
LegG1 do not affect the early steps of LCV formation.
Next, we assessed a possible role of the RCC1 repeat effectors in the activation of
Ran on LCVs. To this end, we employed D. discoideum producing GFP-RanBP1, which
binds only to active Ran(GTP) (47). The amoebae were infected with red fluorescent L.
pneumophila strain JR32, ΔppgA, ΔlegG1, or ΔppgA-ΔlegG1, or with the complemented
mutants. The ER/LCV marker calnexin was immunostained in LCV isolates of the
infected cells, and the localization of GFP-RanBP1 was analyzed by confocal fluores-
cence microscopy (Fig. S5A). Due to a low signal-to-noise ratio in intact infected cells,
the recruitment of GFP-RanBP1 was observed only in LCV isolates of infected amoebae.
While around 70% of the LCVs containing JR32 or the ΔppgA mutant stained positively
for GFP-RanBP1, only approximately 40% of LCVs harboring the ΔlegG1 or ΔppgA-
ΔlegG1 mutant strain were decorated with GFP-RanBP1 (Fig. S5B). For LCVs harboring
the ΔlegG1 mutant strain, the localization of GFP-RanBP1 was restored to wild-type
levels by providing legG1 on a plasmid under the control of the Ptac promoter. Taken
together, these findings confirm that LegG1 promotes Ran activation on LCVs (47) and
indicate that PpgA is dispensable for RanBP1 accumulation on LCVs. Hence, PpgA
might be targeted to another cellular compartment.
Swart et al. ®













































To test the hypothesis that PpgA localizes to cellular compartments other than LCVs,
we used D. discoideum ectopically producing GFP-PpgA, GFP-LegG1, or GFP-
LegG1ΔCAAX (lacking the C-terminal prenylation motif). The amoebae were left unin-
fected or were infected with red fluorescent L. pneumophila JR32 or the ΔicmT mutant
strain, and localization of RCC1 repeat effectors was analyzed by microscopy. GFP-PpgA
was produced by fewer cells than GFP-LegG1 (data not shown) but localized clearly and
almost exclusively to the plasma membrane in uninfected D. discoideum, as well as in
amoebae infected with virulent or avirulent L. pneumophila (Fig. 2H). PpgA-dependent
activation of Ran on the plasma membrane through recruitment of GFP-RanBP1 could
not be observed, likely because of the low signal-to-noise ratio, which also precluded
visualization of the marker on LCVs in intact infected cells (Fig. S5A). In contrast to
GFP-PpgA, GFP-LegG1 showed punctate staining in the cytoplasm and localized to
pathogen vacuoles harboring JR32 but not ΔicmTmutant bacteria, as shown previously
(47). Upon removal of the C-terminal prenylation motif, GFP-LegG1ΔCAAX no longer
localized to LCVs in D. discoideum (Fig. 2H), in agreement with the C-terminal signature
being required for the localization to specific subcellular membranes in mammalian
cells (51, 52). Finally, in homogenates of infected D. discoideum, V5-tagged LegG1 and
PieG accumulated on LCVs, while V5-tagged PpgA did not localize to the pathogen
vacuoles (Fig. S5C). Taking the results together, while LegG1 localizes to LCVs and
promotes RanBP1 accumulation (Ran activation), PpgA localizes to the eukaryotic
plasma membrane rather than to LCVs and is dispensable for RanBP1 accumulation on
LCVs.
PpgA requires functional RanGAP1 to inhibit yeast growth. For further studies
on targets and the mode of action of L. pneumophila RCC1 repeat effectors, we sought
to employ the yeast Saccharomyces cerevisiae, a model which has previously been
successfully used to assess effects of L. pneumophila effectors on eukaryotic processes
(56, 57). In particular, the use of yeast lethality suppressors has been instrumental to
characterize the mode of action of some effector proteins (58). Many L. pneumophila
effectors target host proteins, which are conserved among eukaryotes. The yeast small
GTPase Gsp1, e.g., is 83% and 72% identical to human Ran and D. discoideum RanA,
respectively.
To validate the use of S. cerevisiae as a model to analyze RCC1 repeat effectors, we
first analyzed the localization of ectopically produced GFP fusion proteins of the
effectors by confocal fluorescence microscopy (Fig. 3A). GFP-PpgA predominantly
localized to the plasma membrane in S. cerevisiae. In contrast, GFP-LegG1 and GFP-PieG
were mostly distributed in the cytoplasm. Thus, the RCC1 repeat effectors localized to
the same (PpgA) or similar (LegG1, PieG) subcellular compartments in amoebae and
yeast, and accordingly, the latter might be a valid model system to functionally
characterize the effectors.
Next, we tested the growth of yeast producing RCC1 repeat effectors by dot spot
assays. S. cerevisiae wild-type strain BY4741 containing an empty plasmid or producing
FLAG-PpgA, FLAG-LegG1, or FLAG-PieG was spotted in 10-fold dilutions on SG plates
without leucine and grown at 20 to 37°C for 3 to 6 days (Fig. 3B; see also Fig. S6A).
Under these conditions, production of FLAG-PpgA inhibited growth of the yeast cells,
at lower temperatures in particular, while production of FLAG-LegG1 or FLAG-PieG did
not affect yeast growth.
To obtain insights into the cellular pathways mediating growth inhibition by PpgA,
we employed S. cerevisiae mutant strains defective for one of the following compo-
nents in the Ran GTPase cycle: rna1-1 (RanGAP1), prp20-1 (RCC1), yrb1-51 (RanBP1), or
yrb2 (RanBP2). FLAG-PpgA, FLAG-LegG1, or FLAG-PieG was produced in these mutant
strains, and growth was assessed by dot spot assays (Fig. 3C). Interestingly, the
production of FLAG-PpgA did not inhibit the growth of S. cerevisiae rna1-1, a
temperature-sensitive mutant strain producing a nonfunctional RanGAP1 protein.
Growth inhibition by FLAG-PpgA was restored upon production of wild-type RNA1 in
the rna1-1 mutant strain (Fig. 3D; see also Fig. S6B). This result indicates that growth
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FIG 3 PpgA requires functional RanGAP1 to inhibit yeast growth. (A) The localization of L. pneumophila RCC1 repeat effectors was analyzed by confocal
microscopy in S. cerevisiae wild-type strain BY4741 producing GFP-PpgA (pLS120), GFP-LegG1 (pLS118), or GFP-PieG (pLS113). Bars, 1 m. (B) Growth of yeast
producing RCC1 repeat proteins was tested by dot spot assays. S. cerevisiae wild-type strain BY4741 containing an empty plasmid (pYEP351gal) or producing
FLAG-PpgA (pLS085), FLAG-LegG1 (pLS084), or FLAG-PieG (pLS086) was spotted in 10-fold dilutions on SG plates without leucine and grown at the indicated
temperatures for 5 (30°C and 37°C), 6 (25°C), or 7 (20°C) days (left panel). Colony size (at 30°C) was measured using ImageJ/Fiji (right panel; n  20; one-way
ANOVA; ***, P  0.001). (C) S. cerevisiae mutant strains rna1-1 (RanGAP1), prp20-1 (RCC1), yrb1-51 (RanBP1), and yrb2 (RanBP2) containing an empty plasmid
(pYEP351gal) or a plasmid producing FLAG-PpgA (pLS085), FLAG-LegG1 (pLS084), or FLAG-PieG (pLS086) were spotted in 10-fold dilutions on SG plates without
leucine and grown at the indicated temperatures for 5 (30°C), 6 (25°C and 37°C), or 7 (20°C) days (left panel). Colony size was measured using ImageJ/Fiji (right
panel) (n  10; one-way ANOVA; ***, P  0.001). (D) S. cerevisiae strain BY4741 or mutant strain rna1-1 containing the empty plasmids pYEP351gal and pRS316,
or pYEP351gal and pRS316-RNA1 (RNA1), pRS316 and pLS085 (FLAG-PpgA), or pRS316-RNA1 (RNA1) and pLS085 (FLAG-PpgA) was spotted in 10-fold dilutions
on SG plates without leucine and uracil and grown at the indicated temperatures for 3 to 6 days. Colony size was measured using ImageJ/Fiji (one-way ANOVA;
n  9; ***, P  0.001). (E) S. cerevisiae wild-type strain BY4741 or mutant strain rna1-1 containing the empty backbone (pYEP351gal) or producing FLAG-PpgA
(pLS085), FLAG-LegG1 (pLS084), or FLAG-PieG (pLS086) was grown in SG medium without leucine for 7 days at 20°C, and OD600 was measured every hour. Data
show means and standard deviations (for simplicity, only the standard deviations at 50 h, 100 h, 150 h, and 167 h are shown) of results from three independent
experiments (two-way ANOVA; **, P  0.01; ***, P  0.001).
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inhibition by PpgA is mediated partially by the Ran GTPase cycle and, more specifically,
requires functional RanGAP1 (RNA1). In order to further confirm the role of RNA1 for the
inhibitory effect of PpgA, growth of S. cerevisiae BY4741 or rna1-1 producing FLAG-
PpgA, FLAG-LegG1, or FLAG-PieG in SG medium without leucine was monitored for
7 days at 20°C, and the optical density at 600 nm (OD600) was measured every hour
(Fig. 3E). Under these conditions, PpgA but not LegG1 or PieG significantly slowed yeast
growth in the wild-type strain, and the growth inhibition mediated by PpgA was
partially alleviated in the rna1-1 mutant strain.
Intriguingly, the production of FLAG-PieG or FLAG-PpgA also inhibited the growth
of the S. cerevisiae yrb1-51 (RanBP1) strain (Fig. 3C), suggesting that PieG and PpgA
might target a RanBP1-dependent pathway. In summary, the L. pneumophila RCC1
repeat effector PpgA inhibited the growth of wild-type yeast in a RanGAP1-dependent
manner, and PieG as well as PpgA inhibited the growth of a strain lacking functional
RanBP1. These findings are in agreement with the notion that different components of
the Ran GTPase cycle are the targets of L. pneumophila RCC1 repeat effectors.
PpgA and LegG1 target distinct Ran GTPase cycle components. To test the
hypothesis that the RNA1-dependent growth inhibition of yeast by PpgA is due to a
direct interaction between the RCC1 repeat effector and the RanGAP1 RNA1, the
putative interaction partners were ectopically produced in S. cerevisiae. Specifically, we
produced Strep-tagged RNA1 or the mutant protein RNA1-1 and FLAG-tagged PpgA or
LegG1 in strain BY4741. The rna1-1 allele contains two single-base-pair substitutions,
resulting in two amino acid changes (S17F and A194V), which impairs enzyme activity
and renders the strain temperature sensitive due to failure of RNA processing and
nuclear export at the nonpermissive temperature (59). The interactions with RCC1
repeat effectors were tested by performing an anti-FLAG co-immunoprecipitation
(co-IP) assay in yeast lysates, followed by anti-Strep Western blotting (Fig. 4A). Using
this approach, FLAG-PpgA bound to RNA1 but not to RNA1-1, while FLAG-LegG1 did
not bind to either host protein. These results indicate that PpgA but not LegG1 interacts
with the RanGAP1 RNA1 and that the RNA1-1 mutations abolish the interaction. Hence,
the PpgA-RNA1 interaction appears to be required for effector function.
In order to identify possible interaction partners and targets of LegG1, we incubated
purified Strep-tagged LegG133–286 (LegG1 lacking only the 32 N-terminal amino acids)
with HEK 293T cell lysates, treated these with Strep-Tactin resin, and separated the
eluate by SDS-PAGE (Fig. 4B). Under the conditions used, several proteins eluted from
the beads and were identified by mass spectrometry (Table S2B and C). Among the
proteins identified were Ran GTPase, RanGAP1, RanBP1, RanBP9, and RanBP10, a
cytoplasmic Ran GEF implicated in the modulation of noncentrosomal microtubules
(45).
To assess the interaction between L. pneumophila RCC1 repeat effectors and po-
tential interaction partners, we employed yeast two-hybrid assays (Fig. 4C and D). To
this end, we fused LegG1 to the GAL4 activation domain (AD) and RanBP10, RanGAP1,
Ran (WT), or different Ran mutants to the GAL4 DNA binding domain (BD). Moreover,
we fused LegG1, PpgA, or PieG to the GAL4 activation domain and RanBP10 to the
GAL4 DNA binding domain. Transformants of the AH109 reporter strain were spotted
in 10-fold serial dilutions onto SD lacking His (His) or SD plus His (His) and incubated
at 30°C for 5 days. While all of the yeast strains grew in the presence of His (growth
control), the strain harboring AD-LegG1 and BD-RanBP10 but not BD-RanGAP1 or
BD-Ran (wild type, constitutively active, dominant negative) grew in the absence of His
(Fig. 4C and D). Hence, among the putative interactions of LegG1 with Ran cycle
components detected by the sensitive mass spectrometry approach, only the robust
interaction with RanBP10 was validated. Under selective conditions, no growth was
observed for yeast strains producing AD-PpgA or AD-PieG or strains harboring the AD
or BD empty vectors. Collectively, these data confirm that LegG1 specifically binds to
the cytoplasmic Ran GEF, RanBP10, but neither PpgA nor PieG does so.
Legionella RCC1 Repeat Effector Evolution and Targets ®













































RanGAP1 is implicated in intracellular L. pneumophila replication. Previously,
we found that the depletion of Ran or RanBP1 by RNA interference reduces intracellular
growth of L. pneumophila (47). To assess whether RanGAP1 and RanBP10 play a role in
intracellular replication of the pathogen, the proteins were individually depleted. To
this end, human A549 lung epithelial cells were treated with small interfering RNA
FIG 4 PpgA and LegG1 target distinct Ran GTPase cycle components and promote Ran activation. (A) S. cerevisiae BY4741 ectopically producing Strep-tagged
RNA1 (pLS128) or RNA1-1 (pLS127) and FLAG-tagged PpgA (pLS085) or LegG1 (pLS084) was lysed, a co-IP with anti-FLAG was performed, and interactions were
revealed by anti-Strep Western blotting. Yeast lysates were analyzed by Western blotting with anti-Strep (input control) and anti-FLAG (co-IP control). (B) Lysates
of HEK 293T cells were incubated with Strep-LegG133–286 bound to Strep-Tactin resin, and interaction partners were identified by mass spectrometry. (C) Yeast
two-hybrid assays using S. cerevisiae reporter strain AH109 containing plasmids encoding the GAL4 DNA-binding domain (BD; pGBKT7) alone or fused to
RanBP10 (pLS213), RanGAP1 (pM1593), Ran_WT (pM1057), Ran_T24N (pM1059), Ran_Q69L (pM1058), or Ran_N122D (pM1286) and the GAL4 activation domain
(AD) fused to LegG1 (pLS211). Transformants were spotted onto SD lacking His (His) or SD plus His (His) and incubated at 30°C for 5 days. (D) Yeast
two-hybrid assay in reporter strain AH109 containing plasmids encoding the GAL4 DNA-binding domain (BD; pGBKT7) alone or fused to RanBP10 (pLS213) and
the GAL4 activation domain (AD; pGADT7) alone or fused to LegG1 (pLS211), PpgA (pM1028) or PieG (pM1027). Transformants were spotted in 10-fold serial
dilutions onto SD lacking His (His) or SD plus His (SD) and incubated at 30°C for 5 days. (E) Human A549 cells transfected for 48 h with 10 nM siRNA
oligonucleotides targeting RanGAP1, RanBP10, or Arf1 (positive control) or with AllStars siRNA (“scrambled”) were infected (MOI 10) with GFP-producing L.
pneumophila JR32 (pNT28). Intracellular bacterial replication was assessed by fluorescence increase with a fluorescence plate reader after 24 h and compared
to the levels seen at 1 h. Means and standard deviations of results from three independent experiments are shown (one-way ANOVA; **, P  0.01; all groups
compared to scrambled). (F) The depletion efficiency of siRNA oligonucleotides targeting RanGAP1 or RanBP10 upon transfection of A549 epithelial cells for
48 h was assessed by Western blotting with the antibodies indicated. For each target protein four different oligonucleotides were used. Untreated cells were
used as a negative control (“Untr.”), Qiagen AllStars unspecific oligonucleotides (“Scrambled,” “Scr.”) were used to control for off-target effects, and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) served as the loading control. Data are representative of results from two independent experiments. (G) HEK 293T
cells were transfected for 24 h with constructs producing Strep-tagged PpgA (pLS229), LegG1 (pLS226), PieG (pLS230), or RCC1 (pLS231). Nontransfected cells
(-) were taken along, and lysates were treated with GTPS (positive control) or GDP (negative control). Ran(GTP) was precipitated with RanBP1-coupled agarose
beads in cell lysates, and the amount of Ran(GTP), total Ran, and GAPDH (loading control) was assessed by Western blotting (top panel). The amount of Ran(GTP)
relative to total Ran was quantified using ImageQuant TL (bottom panel). Means and standard deviations of results from three independent experiments are
shown for the first four bands (one-way ANOVA; *, P  0.05; **, P  0.01; ***, P  0.001; all groups compared to the nontransfected cells [-]).
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(siRNA) oligonucleotides targeting RanGAP1, RanBP10, or Arf1 (positive control), and
intracellular replication of GFP-producing L. pneumophila was monitored by fluores-
cence after 24 h (Fig. 4E), as previously described (37, 47, 60). Under the conditions
described and in the medium used, L. pneumophila grows only intracellularly, and the
GFP production (fluorescence intensity) is proportional to the number of bacteria
(expressed in CFU counts). Upon depletion of RanGAP1, the fluorescence intensity of
intracellular L. pneumophila was reduced approximately 2-fold, indicating that Ran
inactivation plays a role in efficient intracellular growth of L. pneumophila. In contrast,
the depletion of RanBP10 did not have a significant effect. The depletion of Arf1
reduced intracellular growth of L. pneumophila to a similar extent as depletion of
RanGAP1. The treatment with siRNA oligonucleotides efficiently depleted RanGAP1 or
RanBP10 (Fig. 4F), but had no effect on host cell viability (data not shown). Taken
together, the results indicate that the depletion of RanGAP1 reduces the intracellular
replication of L. pneumophila without affecting the host cell physiology, while the Ran
GEF RanBP10 is dispensable or plays a redundant role for intracellular growth of the
pathogen.
Ectopic production of RCC1 repeat effectors promotes Ran activation. Given
that the L. pneumophila RCC1 repeat effectors target different components of the Ran
GTPase cycle, we assessed their effect on Ran activation. To this end, we ectopically
produced Strep-tagged PpgA, LegG1, PieG, or RCC1 in HEK 293T cells. After cell lysis,
active Ran was precipitated with RanBP1-coupled agarose beads, and the amount of
Ran(GTP) was determined by Western blotting (Fig. 4G). Upon production of the L.
pneumophila RCC1 repeat proteins, the cellular amount of Ran(GTP) was increased by
2-fold to 3-fold compared to the control. As expected, overproduction of Strep-RCC1
significantly increased the amount of active Ran GTPase, as did incubation of the
cleared lysate with a slowly hydrolyzable form of GTP, GTPS, but not GDP. These
results demonstrate that while the bacterial effectors target distinct components of the
Ran GTPase cycle, they all promote the activation of the small GTPase, albeit less
efficiently than ectopically produced RCC1.
The Lpg1975-LegG1 fusion protein adopts PieG substrate specificity. An inter-
esting pattern seen among all but one of the sequenced L. pneumophila genomes was
that if two RCC1 paralogs were present in a genome, one of them was split (Fig. 1).
Thus, the single RCC1 repeat gene in strain Paris, pieG, was split in strain Philadelphia-1
into legG1 and the upstream gene, lpg1975. A single point mutation in the gene
corresponding to pieG (deletion of a thymidine phosphate) caused a frameshift and
resulted in the two open reading frames, lpg1975 and legG1 (Fig. 5A). This pattern is
conserved and was observed for at least 31 L. pneumophila strains (Fig. 1). Reverting the
frameshift mutation, we created the lpg1975-legG1 fusion by insertion of a thymidine
phosphate. The corresponding Lpg1975-LegG1 fusion protein (strain Philadelphia-1) is
approximately 90% identical to PieG (strain Paris) (Fig. S7). In order to characterize
potential functional consequences of the point mutation leading to split PieG, we
assessed the host cell localization and targets of the L. pneumophila RCC1 repeat
effectors.
Similarly to LegG1 from strain Philadelphia-1, PieG from strain Paris localizes to LCVs
(Fig. S5C). In order to identify potential interaction partners and targets of the RCC1
repeat effectors, a co-IP screen was performed with yeast producing FLAG-tagged
PpgA, LegG1, PieG, or Lpg1975-LegG1 (Fusion) and RNA1-Strep (RanGAP1), Strep-
PRP20 (RCC1), Strep-YRB1 (RanBP1), or Strep-GSP1 (Ran). Yeast lysates were incubated
with anti-FLAG beads, and eluates were analyzed for co-IP of Strep-tagged host
proteins by anti-Strep Western blotting (Fig. 5B). Strikingly, FLAG-PieG as well as the
FLAG-Lpg1975-LegG1 fusion protein, but not FLAG-LegG1, bound both RNA1-Strep
(RanGAP1) and Strep-GSP1 (Ran). As observed before, FLAG-PpgA interacted with
RNA1-Strep (RanGAP1). Under these conditions, LegG1 did not bind to any of the Ran
GTPase cycle components tested. These results indicate that the Lpg1975-LegG1 fusion
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protein created upon insertion of a single nucleotide targets the same Ran GTPase cycle
components as PieG.
To confirm these results with endogenous GSP1 (Ran), we produced FLAG-tagged
PpgA, LegG1, Lpg1975-LegG1 (Fusion), or PieG in the S. cerevisiae wild-type strain and
incubated lysates with FLAG-agarose beads. Eluates from the beads were analyzed for
the co-IP of endogenous GSP1 using an anti-GSP1 antibody (Fig. 5C). Under these
conditions, FLAG-PieG as well as the FLAG-Lpg1975-LegG1 fusion protein precipitated
GSP1 (Ran), while LegG1 did not.
In order to assess the RCC1 repeat effector targets in mammalian cells, we per-
formed co-IP experiments in HEK 293T cells (Fig. 5D). To this end, the cells were
transfected with a plasmid producing Strep-RanBP10 and plasmids producing GFP-
Lpg1975, GFP-LegG1, GFP-Lpg1975-LegG1 (Fusion), GFP-PpgA, GFP-PieG, or GFP-
PieG_split (corresponding to LegG1). Cell lysates were incubated with anti-Strep anti-
body and protein A/G agarose beads, and eluates were analyzed for co-IP of GFP using
an anti-GFP antibody. Under these conditions, RanBP10 was bound by LegG1, validat-
ing the binding studies performed in yeast (Fig. 4). Moreover, RanBP10 was weakly
FIG 5 PieG and the fusion protein Lpg1975-LegG1 interact with Ran and RanGAP1. (A) A point mutation (insertion of thymidine phosphate) in L. pneumophila
lpg1975 (strain Philadelphia-1) causes a frameshift and fuses the open reading frames of lpg1975 and legG1 (lpg1976), resulting in a fusion gene with high
homology to pieG (strain Paris). (B) A co-IP screen was performed with yeast coproducing FLAG-PpgA (pLS085), FLAG-LegG1 (pLS084), FLAG-PieG (pLS086), or
FLAG-Lpg1975-LegG1 fusion (pLS087) and RNA1-Strep (pLS128), Strep-PRP20 (pLS185), Strep-YRB1 (pLS186), or Strep-GSP1 (pLS173). Yeast lysates were
incubated with FLAG beads, and eluates were analyzed for co-IP of Strep-proteins by anti-Strep Western blotting. Yeast lysates were analyzed by Western
blotting with anti-Strep (input control) and anti-FLAG (co-IP control). (C) Lysates of yeast harboring pYEP351gal-FLAG-ppgA (pLS085), pYEP351gal-FLAG-legG1
(pLS084), pYEP351gal-FLAG-lpg1975-legG1 fusion (pLS087), or pYEP351gal-FLAG-pieG (pLS086) were incubated with FLAG-agarose beads, and eluates were
analyzed for the co-IP of endogenous GSP1 using a specific antibody. (D) HEK 293T cells were transfected for 24 h with plasmids harboring GFP-Lpg1975
(pLS233), GFP-LegG1 (pLS227), GFP-Lpg1975-LegG1 (Fusion) (pLS234), GFP-PpgA (pLS095), GFP-PieG (pLS093), or GFP-PieG_split (pLS235) and Strep-RanBP10
(pLS242). Cell lysates were analyzed by anti-GFP Western blotting (input control), or incubated with anti-Strep antibody and A/G agarose beads, and eluates
were analyzed by Western blotting for co-IP of GFP fusion proteins using anti-GFP and anti-Strep (co-IP control). (E) Real-time fluorescence microscopy of LCV
motility in D. discoideum producing calnexin-GFP (pCaln-GFP) (green) infected (MOI 5, 1 to 2 h) with L. pneumophila JR32 (WT) or with the ΔlegG1-ΔppgAmutant
producing DsRed alone (pCR077) or together with M45-tagged PieG (pLS033), Lpg1975-LegG1 fusion protein (pLS026), LegG1 (pER005), or PpgA (pLS008). LCV
motility was recorded for 180 s with images taken every 10 s and quantified using ImageJ/Fiji software with the manual tracking plugin (n  50/strain; 3
independent experiments; one-way ANOVA; ***, P  0.001; all groups compared to ΔlegG1-ΔppgA).
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bound by Lpg1975 as well as by the Lpg1975-LegG1 fusion protein, but not at all by
PieG or the C-terminal part of PieG (PieG_split), which corresponds to but is not
identical with LegG1.
Finally, to assess whether the Lpg1975-LegG1 fusion protein can functionally replace
PieG, we sought to complement the LCV motility phenotype of the ΔlegG1-ppgA
double mutant strain (Fig. 5E). D. discoideum producing the ER/LCV marker calnexin-
GFP was infected with the red fluorescent L. pneumophila wild-type strain or with the
ΔlegG1-ΔppgA mutant producing M45-tagged PieG, Lpg1975-LegG1 fusion protein,
LegG1, or PpgA, and LCV motility was recorded by fluorescence microscopy. The LCV
motility defect of the ΔlegG1-ppgA double mutant strain was restored to similar
extents by Lpg1975-LegG1, PieG, and LegG1, indicating that the fusion protein is
functional.
In summary, the results of this study indicate that the divergent evolution of L.
pneumophila RCC1 repeat effectors defines the range of Ran GTPase cycle targets.
Accordingly, PpgA targets RanGAP1, LegG1 binds RanBP10, and PieG as well as the
Lpg1975-LegG1 fusion interact with Ran and RanGAP1 (Fig. 6; see also Table 1). The L.
pneumophila RCC1 repeat effectors promote the activation of Ran GTPase, and thus, our
working model stipulates that LegG1 activates the GEF RanBP10, PpgA inhibits Ran-
GAP1, and PieG stabilizes Ran(GTP) and/or inhibits RanGAP1.
DISCUSSION
The presence of many “eukaryote-like” genes in the L. pneumophila genome (i.e.,
genes whose closest homologue is found in eukaryotes) reflects an intimate relation-
ship and exchange of genetic material between the facultative intracellular pathogen
and its protozoan hosts (48–50). In this study, we investigated the evolution and
functions of Legionella effectors containing the eukaryotic RCC1 repeat, which is
implicated in the activation of the small GTPase Ran. Bioinformatics revealed that RCC1
repeat genes are present in many Legionella species (24 of 58 analyzed). Only a few, if
any, of these RCC1 genes appeared to be orthologues of lpp1959 (pieG). In any case,
FIG 6 Ran GTPase cycle targets of L. pneumophila RCC1 repeat effectors. The different Ran GTPase cycle
targets of the L. pneumophila RCC1 repeat effectors LegG1, PpgA and PieG (red) are indicated. Divergent
evolution of L. pneumophila RCC1 repeat effectors defines the range of target components of the Ran
GTPase cycle. Regardless of the distinct target, the L. pneumophila RCC1 repeat effectors promote the
activation of Ran. Putative activation (), inhibition (|), or binding (	) of Ran GTPase cycle components
by L. pneumophila RCC1 repeat effectors is indicated with different arrow endings. For details see text.




LCV motility Increased Increased Increased
Cellular localization Plasma membrane LCV membrane LCV membrane
Cell migration Increased Increased Not tested
Yeast growth (wild-type) Reduced Not affected Not affected
Ran cycle target(s) RanGAP1 RanBP10 Ran and RanGAP1
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none of these RCC1 genes was shorter than lpp1959, ruling out the presence of a split
pieG gene in Legionella species other than L. pneumophila.
The RCC1 repeat genes are conserved in all L. pneumophila strains analyzed (Fig. 1).
The strains harboring one RCC1 repeat effector gene (e.g., pieG in strain Paris or Lens)
do not form a single cluster in the phylogenetic tree. In contrast, strains harboring two
RCC1 repeat genes (a split pieG: legG1, and ppgA) form a distinct cluster and thus share
a common ancestor. In case of split pieG, only one gene (legG1) contains a predicted
RCC1 repeat. A few strains in the Lens-Paris cluster form a subcluster and contain pieG
and in addition two or three copies of ppgA. This subcluster likely acquired the ppgA
gene(s) after pieG. On the basis of the overall phylogeny, an ancestral L. pneumophila
strain harboring pieG might have acquired the ppgA gene(s). However, we cannot
exclude the possibility that the RCC1 repeat gene distribution in L. pneumophila is the
result of an ancestral strain harboring both pieG and ppgA, where duplication of ppgA
took place in some strains, loss of ppgA in others, and retention and splitting of pieG in
the majority.
Interestingly, when two RCC1 repeat genes are present in a L. pneumophila genome,
one of them is split. On the basis of the available data, we cannot deduce whether in
the course of genome evolution the split of pieG (yielding legG1 and lpg1975) or the
acquisition of ppgA happened first. While pieG and ppgA occur together in strain
HL06041035, in this case one ppgA copy also suffered a major mutation (internal
deletion). Hence, there seems to be considerable evolutionary pressure on the RCC1
repeat genes, originating either from the challenging host cell interactions (see below)
or from the requirements to produce a eukaryotic protein in a prokaryote. In any case,
L. pneumophila as well as Escherichia coli and Yersinia enterocolitica efficiently produce
the “trimmed” version of PieG, LegG1. Moreover, Y. enterocolitica was found to produce
active LegG1, which upon delivery into eukaryotic cells promoted microtubule stabili-
zation (47). Given that LegG1 promotes microtubule stabilization upon this “microbial
microinjection” by Y. enterocolitica and that the L. pneumophila ΔlegG1 mutant strain
has strong and pleiotropic phenotypes, the RCC1 repeat gene is likely not on the path
to pseudogenization.
The deletion of a single nucleotide in the gene of strain Philadelphia-1 correspond-
ing to pieG of strain Paris leads to a frameshift and, consequently, to two open reading
frames in the genome of Philadelphia-1: lpg1975 and legG1 (Fig. 5A). The consequences
of this point mutation are remarkable on the protein level. While PieG (53 kDa) binds
Ran as well as RanGAP1, LegG1 (31 kDa) specifically binds the cytoplasmic Ran GEF,
RanBP10 (Fig. 4 and 5). Strikingly, this substrate switch can be experimentally reversed
by introducing an additional nucleotide in the lpg1975-legG1 sequence, thus restoring
the production of the Lpg1975-LegG1 fusion protein with the binding characteristics of
PieG (Fig. 5).
Ran is a pleiotropic small GTPase implicated in diverse cellular processes such as
nucleocytoplasmic transport as well as mitotic and nonmitotic microtubule dynamics
(39, 40). The depletion by RNA interference of Ran or its effector RanBP1 (binding only
to activated Ran) inhibits the intracellular replication of L. pneumophila, and both Ran
and RanBP1 localize to LCVs (47). The prenylated Icm/Dot substrate LegG1 promotes
local Ran activation on LCVs, microtubule stabilization, and LCV motility (47). The
sustained LCV dynamics along microtubules likely uphold the interactions of the
pathogen vacuole with cellular vesicles throughout the bacterial infection. Moreover,
LegG1 induces mitochondrial fragmentation during infection and thus also seems to
affect microtubule dynamics at a distance from the pathogen compartment (54).
Finally, LegG1 stimulates the chemotactic migration of D. discoideum amoebae, mac-
rophages, and neutrophils (53). Yet it is not clear whether this effect has direct
implications for L. pneumophila virulence or whether it is an indirect consequence of
microtubule stabilization.
Given the pleiotropic functions of Ran GTPase, its unrestricted activation is likely
detrimental to host cells. In agreement with this notion, ectopic production of PpgA in
yeast inhibited the growth and was potentially toxic for the cells (Fig. 3B; see also
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Fig. S6A in the supplemental material). In order to avoid a potentially disruptive
activation of Ran, its subversion by a pathogen must be tightly controlled regarding the
specificity, localization, secretion hierarchy, and half-live of the effector(s). Our results
revealed that PpgA interacted with RanGAP1, LegG1 bound the cytosolic GEF RanBP10,
and PieG bound Ran GTPase as well as RanGAP1 (Fig. 4 and 5). Thus, effector substrate
expansion due to the presence of two or more RCC1 repeat effectors in a given L.
pneumophila strain might fine-tune Ran activation during Legionella infection, and
strains harboring distinct combinations of RCC1 repeat effectors might affect Ran
activation differently. Targeting of Ran modulators allows the effectors to exploit the
inherent specificity of these modulators, and thus, several layers and levels of control
can be achieved. Moreover, the injection timing and hierarchy as well as the host cell
half-life of L. pneumophila effectors might affect Ran activation; however, these intricate
and complex issues have not been addressed thus far.
Furthermore, we provide evidence for distinct manifestations of spatial control, i.e.,
different subcellular localizations of L. pneumophila RCC1 repeat effectors. LegG1 and
PieG localize to the LCV membrane, and this localization is dependent on the
C-terminal CAAX prenylation motif (Fig. 2H; see also Fig. S5C) (47, 52). In contrast, PpgA
exclusively localizes to the plasma membrane in D. discoideum amoebae as well as in
the yeast model (Fig. 2H and 3A). The specific localization of PpgA and its binding to
RanGAP1 suggest a function of Ran at the plasma membrane which to our knowledge
has not been described before. Alternatively, RanGAP1 might have Ran-independent
functions at the plasma membrane. The subcellular localization of PpgA at the plasma
membrane is congruent with a role in cell migration and chemotaxis (Fig. 2G). An
elaborate form of spatiotemporal control of Ran activation by different L. pneumophila
RCC1 repeat effectors might also explain the apparently counterintuitive finding that
depletion of Ran as well as depletion of its inhibitor, RanGAP1, reduced intracellular
growth of L. pneumophila (Fig. 4E) (47). Again, these findings are also in agreement with
Ran-independent functions of RanGAP1. Taken together, in addition to substrate
expansion, different subcellular localizations of L. pneumophila RCC1 repeat effectors
might contribute to control Ran activation in infected host cells. A sophisticated and
fine-tuned form of spatiotemporal control of Ran activation might indeed be the
evolutionary driving force behind the acquisition of the second RCC1 repeat effector,
PpgA, in the L. pneumophila Philadelphia-C7O cluster (Fig. 1).
At this point, we cannot rule out the possibility that PpgA also functions at other
sites in the cell. The motility of LCVs harboring a ΔppgA mutant strain was reduced
similarly to that of LCVs harboring ΔlegG1 (Fig. 2D; see also Fig. S4A). However, PpgA
appeared to be dispensable for Ran activation directly on LCVs, since Ran was still
activated on the pathogen vacuoles harboring ΔppgA (as judged by accumulation of
GFP-RanBP1) (Fig. S5A and B). The different subcellular localizations (and possibly
functions) of PpgA and LegG1 are also reflected in the fact that plasmid-borne legG1
restored the LCV motility phenotype of the ΔppgA mutant strain whereas ppgA had no
effect on the corresponding ΔlegG1 phenotype (Fig. 2D; see also Fig. S4A). Notably,
these findings are also in agreement with the presence of a Ran activation pathway
where PpgA precedes LegG1. In addition to its role in pathogen vacuole motility and
microtubule stabilization, LegG1 (alias MitF) has been implicated in microtubule-
dependent organelle dynamics. LegG1 promotes the fission of the mitochondrial
network through the accumulation of a mitochondrial large GTPase, DNM1L. Mitochon-
drial fission halts respiration and shifts the host cell metabolism toward glycolysis in a
process called the “Warburg effect.”
The L. pneumophila RCC1 repeat effectors LegG1, PpgA, and PieG play an important
role in pathogen-host interactions (Fig. 2; see also Fig. S3) (47) and, upon ectopic
production, function as bacterial Ran activators [i.e., cause the cytoplasmic levels of
Ran(GTP) to increase], albeit less efficiently than RCC1 (Fig. 4G) (47). Perhaps the RCC1
repeat effectors are less efficiently produced in eukaryotic cells, which might at least
partially account for their rather inefficient Ran activation, or perhaps they are less
efficient than RCC1, because they indirectly activate Ran by targeting Ran-modifying
Legionella RCC1 Repeat Effector Evolution and Targets ®













































proteins. Plausible mode of actions for the different RCC1 repeat effectors to increase
cellular levels of Ran(GTP) are that LegG1 activates the GEF RanBP10, PpgA inhibits the
GAP RanGAP1, and PieG and the Lpg1975-LegG1 fusion protein stabilize Ran(GTP) by
binding to the active GTPase and/or inhibit RanGAP1 (Fig. 6; see also Table 1).
The further investigation of the mode of action of RCC1 repeat effectors requires
their purification and biochemical analysis. However, our attempts to purify PpgA or
PieG from E. coli or from L. pneumophila overproducing the effectors have thus far
remained unsuccessful. Production of various recombinant fusion proteins, including
His, GST, GFP, and MBP fusions, at different temperatures resulted in large amounts of
aggregated insoluble protein. Efforts to improve protein folding, e.g., coproduction of
bacterial chaperones, failed to increase the yield of soluble protein. In summary, on the
basis of bioinformatic, genetic, and cell biological insights, this study shed light on the
divergent evolution of L. pneumophila RCC1 repeat proteins, leading to an expansion of
their substrate range and thus possibly allowing fine-tuning of Ran activation. This work
paves the way for further mechanistic analysis of L. pneumophila RCC1 repeat effectors.
MATERIALS AND METHODS
See Text S1 in the supplemental material for additional detailed descriptions of the materials and
methods used in the study.
Bioinformatics analysis. The Pfam tool (61) was used for the identification of RCC1 proteins in L.
pneumophila genomes. A phylogenetic tree of the 59 fully sequenced L. pneumophila genomes examined
in this study was constructed using Parsnp, a fast core-genome multialignment tool, with default
parameters, removing recombinant regions (62). The orthologous relationships among the proteins of all
the selected strains were obtained by running OrthoMCL (63) with an inflation index of 2.5.
Strains and plasmids. The L. pneumophila and S. cerevisiae strains used in this study are listed in
Table S1A in the supplemental material. Cultivation and transformations were performed according to
established protocols. Construction of L. pneumophila mutant strains was performed as previously
described (64). Plasmids and oligonucleotides used in this study are listed in Table S1A and B,
respectively. All recombinant DNA techniques were employed according to established procedures using
E. coli TOP10 cells.
Host cell infection. L. pneumophila strains (Table S1A) were grown on charcoal-yeast extract (CYE)
agar plates. For infection, liquid cultures in ACES [N-(2-acetamido)-2-aminoethanesulfonic acid] yeast
extract (AYE) medium were inoculated at an OD600 of 0.1 and grown at 37°C to the early stationary phase.
Chloramphenicol (Cam; 5 g/ml) and isopropyl--D-thiogalactopyranoside (IPTG; 1 mM) were added as
required. Cultures were diluted to the desired density (multiplicity of infection [MOI] 0.1 to 50), infections
of phagocytes were synchronized by centrifugation (450 	 g, 10 min at room temperature [RT]), and
infected cells were incubated at the indicated temperature for the indicated time. Intracellular replication
and competition assays were performed as described in Text S1.
(Real-time) fluorescence microscopy. Microscopy was performed with a Leica SP8 inverse laser
scanning confocal microscope using D. discoideum amoebae or S. cerevisiae producing GFP fusion
proteins. Live-cell experiments were performed in imaging dishes (Ibidi), or cells were fixed on poly-L-
lysine-coated coverslips and stained with primary and secondary antibodies as indicated. Intact LCVs
were purified by the two-step immunoaffinity procedure as described previously (36, 37).
Imaging flow cytometry. D. discoideum cells producing GFP fusion proteins were infected with
DsRed-producing L. pneumophila strains and analyzed at the indicated time points by IFC (ImageStream
X Mk II; Amnis) as previously described (65).
Yeast methods. For two-hybrid and spot assays, yeast wild-type or mutant strains (Table S1A) were
grown to the logarithmic phase, and 10-fold dilutions were spotted on SD or SG plates as indicated. Yeast
growth was documented by camera, and colony size was quantified by ImageJ.
Co-immunoprecipitation. FLAG-tagged and Strep-tagged proteins were coproduced in yeast and
affinity purified using anti-FLAG M2 affinity gel (Sigma) according to the manufacturer’s protocol.
Samples were analyzed for the presence of endogenous or Strep-tagged proteins by Western blotting as
described in detail in Text S1. Strep-tagged LegG133–286, purified from E. coli, was preincubated with HEK
293T cell lysate and subsequently loaded on Strep-Tactin Sepharose (IBA). LegG1 and interaction
partners were eluted with desthiobiotin, subjected to trichloroacetic acid (TCA) precipitation, separated
by SDS-PAGE, and analyzed by mass spectrometry. To confirm the interaction between LegG1 and
RanBP10 observed by yeast two-hybrid assay, HEK 293T cells were cotransfected using Lipofectamine
3000 reagent (Invitrogen) with plasmids, producing GFP-tagged Lpg1975, LegG1, Lpg1975-LegG1 (fu-
sion), PpgA, PieG, or PieG190–475 and Strep-tagged RanBP10. The co-IP was performed using an antibody
against Strep tag and A/G agarose beads.
Mass spectrometry analysis. For protein identification, tryptic peptides were separated and ana-
lyzed by nano-high-performance liquid chromatography (nano-HPLC)/tandem mass spectrometry (MS/
MS), and data evaluation was performed using MaxQuant software (66) (v.1.5.3.30) or Perseus software
(67) (v. 1.5.2.6).
Ran activation assay. The cellular amount of Ran(GTP) was analyzed using a Ran activation assay kit
(Cell Biolabs). HEK 293T cells were transfected for 24 h with pEGFP derivatives using Lipofectamine 3000
Swart et al. ®













































(Invitrogen). Cells were lysed, and Ran(GTP) was precipitated by the use of RanBP1 PBD agarose beads.
Proteins were eluted from beads and analyzed by Western blotting as described in detail in Text S1.
RNA interference and determination of protein depletion efficiency. RNA interference experi-
ments were performed as described previously (47, 60), and the siRNA oligonucleotides used are listed
in Table S1C.
Data availability. All data are available in the main text or in Text S1 (provided as source data files).
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